SIMULATIONS PLUS, INC. (SLP)
Simulations Plus Expands Global Access to Model-Informed Drug Development Training Through Its 2026 Spring School
Simulations Plus Expands Global Access to Model-Informed Drug Development Training Through Its 2026 Spring School
Net Asset Value(s)
Register of shareholders, changes and capital status – conversion into shares of BONDS series 2
Artelo Announces Peer-Reviewed Publication Supporting its FABP5 Inhibitor ART26.12 as a Novel Pain Treatment with a Potentially First-in-Class Profile
RedCloud to Enter Live Deployment Phase as Combined Turkey and Saudi Joint Ventures Represent Up to $80 Million Revenue
Artelo Announces Peer-Reviewed Publication Supporting its FABP5 Inhibitor ART26.12 as a Novel Pain Treatment with a Potentially First-in-Class Profile
Medtronic completes acquisition of CathWorks, expanding its leadership in transforming care for patients with cardiovascular disease